Saratoga Health & Biotechnology Fund

Scorecard
1 / 5 Stars
Lipper
1 1 5 1 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
3 / 5 Stars
TheStreet.com
A+ (Buy)

Fund Fees

Updated 12.31.2013

Maximum Sales Fees %
Initial 5.75
Deferred

Updated 12.31.2013

Maximum Fees %
Administrative
Management 1.25
Redemption 2.0

Updated 12.31.2013

Actual Fees %
12b-1 0.4
Management 1.25
Net Expense Ratio: Annual Report 2.6
Net Expense Ratio: Prospectus 2.6

Updated 03.05.2014

Total Cost Projections
3-Year $1,337.00
5-Year $1,876.00
10-Year $3,341.00

Purchase Information

Updated 12.31.2013

Minimum Investments
Initial $250.00
Additional
Initial IRA
Additional IRA
Initial AIP
Additional AIP